Skip to content

The effect of postoperative negative pressure wound therapy on the incidence of wound dehiscence in high risk patients

Dehiscence Prevention Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON28116
Enrollment
51
Registered
2016-04-25
Start date
2015-02-12
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Humans, post operative care, elective abdominale surgery, elective othopedic surgery, elective vascular surgery, elective plastic surgery (Deep Internal Epigastric Perforator flap (DIEP-flap) and Profunda Artery Perforator flap (PAP-flap), wound dehiscence

Interventions

In the experimental group Prevena™ Incision Management System is applicated in clean closed surgical incisions. In the controlgroup a simple cotton wound dressing is applicated in clean closed surgic

Sponsors

Radboud University Medical Center Postbus 9101, 6500 HB Nijmegen 10 (NL) Geert Grooteplein-Zuid Department of Plastic Surgery
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: * male and female persons * age 18 years or older * signed informed consent form * able to understand the Dutch language * able to understand procedures and instructions * patients undergoing one of the following elective sugical procedures: o plastic surgery through a transverse abdominal (DIEP flap) or sublgluteal (PAP flap) incision * patients with at least one risk factor for wound dehiscence like: o chronic obstructive pulmonary disease o diabetes mellitus o peripheral artery disease o body mass index >30 o smoking o radiotherapy in history o earlier surgery in the same area o traction on the suture line

Exclusion criteria

Exclusion criteria: - incompetence - open fracture - fistula(s) in the area of the incision - simultaneous participation in another scientific study

Design outcomes

Primary

MeasureTime frame
wound dehiscence measured by visible wound dehiscence (wound dehiscence was measured in centimeters)

Secondary

MeasureTime frame
1 surgical site infection measured when clinical signs of surgical site infection are present and by measuring the temperature of the body 2 pain is measured by asking for the patiënt's pain experience by using the Numeric Rating Scale of Pain (NRS) 3 allergy on the wound dressing measured by signs of allergy like: erythema, itch, edema, hematoma

Contacts

Public ContactEmmy Muller-Sloof

Radboud University Medical Center

Emmy.Muller-Sloof@Radboudumc.nlM 00 31 (0) 611090325

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)